2026-04-14T09:09:06Zhttps://recercat.cat/oai/request

oai:recercat.cat:10230/527882026-03-17T01:50:28Zcom_2072_6col_2072_452952

Pityriasis rosea developing after COVID-19 vaccination Marcantonio-Santa Cruz, Orianna Yilsy Vidal-Navarro, Ainhoa Pesqué, David Giménez Arnau, Anna Maria Pujol Vallverdú, Ramon Maria Martín Ezquerra, Gemma 2022-03-29T06:41:53Z 2021 info:eu-repo/semantics/article info:eu-repo/semantics/acceptedVersion Marcantonio-Santa Cruz OY, Vidal-Navarro A, Pesqué D, Giménez-Arnau AM, Pujol RM, Martin-Ezquerra G. Pityriasis rosea developing after COVID-19 vaccination. J Eur Acad Dermatol Venereol. 2021 Nov;35(11):e721-e722. DOI: 10.1111/jdv.17498 0926-9959 http://hdl.handle.net/10230/52788 http://dx.doi.org/10.1111/jdv.17498 eng J Eur Acad Dermatol Venereol. 2021 Nov;35(11):e721-e722 This is the peer reviewed version of the following article: Marcantonio-Santa Cruz OY, Vidal-Navarro A, Pesqué D, Giménez-Arnau AM, Pujol RM, Martin-Ezquerra G. Pityriasis rosea developing after COVID-19 vaccination. J Eur Acad Dermatol Venereol. 2021 Nov;35(11):e721-e722. DOI: 10.1111/jdv.17498, which has been published in final form at http://dx.doi.org/10.1111/jdv.17498. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. info:eu-repo/semantics/openAccess application/pdf application/pdf Wiley